Analyst consensus rating
The Chemours Analyst Rating: Buy
Direct answer
The Chemours's consensus rating is Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $18.33.
Forecast evidence checked October 8, 2026.
Get free The Chemours email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $13.83
- Average price target
- $18.33
- High price target
- $24.00
- Low price target
- $15.00
- Low target gap
- +8.5%
- Target upside
- +32.6%
- High target gap
- +73.5%
- Target range width
- 65.1%
- Consensus rating
- Buy
- Analysts
- 9
- Evidence date
- October 8, 2026
- Valid through
- October 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for The Chemours?
The Chemours has a verified Buy consensus. The same dataset has an average price target of $18.33.
How far are The Chemours's low and high targets from the recorded price?
The low target implies +8.5%, while the high target implies +73.5%.
How many analysts are included in The Chemours's consensus?
The verified consensus includes 9 analysts.
How is The Chemours's target upside or downside calculated?
The average target of $18.33 is divided by the recorded price of $13.83, then one is subtracted to produce +32.6%. This does not guarantee a future return.
When was The Chemours's analyst forecast verified?
The data was verified on 2026-10-08. The dataset is valid through 2026-10-15.